U.S. flag

An official website of the United States government

GTR Home > Laboratories > Machaon Diagnostics

Machaon Diagnostics

GTR Lab ID: 505436, Last updated:2022-01-03
Annual Review past due read more


  • Director: Mike Ero, Lab Director
    Phone: 510-839-5600
    Fax: 510-839-6153
    Email: mike.ero@machaondiagnostics.com
  • Director: Brad Lewis, MD, ABIM, FACP, Medical Director
  • Yamini Bynagari, PhD, Director of Clinical Research
    Email: yamini@machaondiagnostics.com
  • James Furgeson, PhD, Staff
  • Aimon Iftikhar, PhD, Staff
  • James Kain, PhD, VP of Genetics
    Email: james.kain@machaondiagnostics.com
  • Sarah King, PhD, Staff
  • Jooeun Lim, PhD, Staff
  • Jihyun Moon, PhD, Staff
  • Connie Ng, Staff
  • Gayatri Raghuraman, PhD, Staff
  • Sutapa Sarkar, PhD, Staff
  • Frances Tran, PhD, Staff
  • Sujatha Venkataramani, PhD, Staff
  • Violet Votin, PhD, Staff

Conditions and tests

  • Adult hypophosphatasia1 test
  • Afibrinogenemia1 test
  • Arthrogryposis, renal dysfunction, and cholestasis 11 test
  • Arthrogryposis, renal dysfunction, and cholestasis 21 test
  • Atypical hemolytic-uremic syndrome with B factor anomaly1 test
  • Atypical hemolytic-uremic syndrome with C3 anomaly1 test
  • Atypical hemolytic-uremic syndrome with I factor anomaly1 test
  • Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly1 test
  • Atypical hemolytic-uremic syndrome with thrombomodulin anomaly1 test
  • Autosomal dominant Alport syndrome1 test
  • Autosomal recessive Alport syndrome1 test
  • Bernard Soulier syndrome1 test
  • Bleeding diathesis due to thromboxane synthesis deficiency1 test
  • CFHR5 deficiency3 tests
  • Childhood hypophosphatasia1 test
  • Ch├ędiak-Higashi syndrome1 test
  • Congenital afibrinogenemia2 tests
  • Congenital amegakaryocytic thrombocytopenia1 test
  • COVID-191 test
  • CYP2C19-related poor drug metabolism2 tests
  • Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder1 test
  • Disorder due cytochrome p450 CYP2D6 variant2 tests
  • Drash syndrome1 test
  • Factor H deficiency2 tests
  • Factor XIII, A subunit, deficiency of1 test
  • Factor XIII, b subunit, deficiency of1 test
  • Familial dysfibrinogenemia1 test
  • Familial hemophagocytic lymphohistiocytosis 21 test
  • Familial hemophagocytic lymphohistiocytosis 32 tests
  • Familial hemophagocytic lymphohistiocytosis 41 test
  • Familial hemophagocytic lymphohistiocytosis 52 tests
  • Familial hemophagocytic lymphohistiocytosis type 11 test
  • Ghosal hematodiaphyseal dysplasia1 test
  • Glanzmann thrombasthenia1 test
  • Gray platelet syndrome1 test
  • Hemolytic uremic syndrome, atypical, susceptibility to, 13 tests
  • Hemophagocytic syndrome1 test
  • Hereditary factor IX deficiency disease2 tests
  • Hereditary factor VIII deficiency disease2 tests
  • Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX11 test
  • Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency1 test
  • Hermansky-Pudlak syndrome 11 test
  • Hermansky-Pudlak syndrome 21 test
  • Hermansky-Pudlak syndrome 31 test
  • Hermansky-Pudlak syndrome 41 test
  • Hermansky-Pudlak syndrome 51 test
  • Hermansky-Pudlak syndrome 61 test
  • Hermansky-Pudlak syndrome 71 test
  • Hermansky-Pudlak syndrome 81 test
  • Infantile hypophosphatasia1 test
  • Leukocyte adhesion deficiency 31 test
  • Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss1 test
  • Macrothrombocytopenia, isolated, 1, autosomal dominant1 test
  • NAFLD11 test
  • Osteogenesis imperfecta type 101 test
  • Osteogenesis imperfecta type 111 test
  • Osteogenesis imperfecta type 121 test
  • Osteogenesis imperfecta type 141 test
  • Osteogenesis imperfecta type 151 test
  • Osteogenesis imperfecta type 161 test
  • Osteogenesis imperfecta type 51 test
  • Osteogenesis imperfecta type 61 test
  • Osteogenesis imperfecta type 71 test
  • Osteogenesis imperfecta type 81 test
  • Osteogenesis imperfecta type 91 test
  • Osteogenesis imperfecta type I1 test
  • Osteogenesis imperfecta type III1 test
  • Osteogenesis imperfecta with normal sclerae, dominant form1 test
  • Osteogenesis imperfecta, recessive perinatal lethal1 test
  • Paris-Trousseau thrombocytopenia1 test
  • Plasminogen deficiency, type I1 test
  • Platelet-type bleeding disorder 101 test
  • Platelet-type bleeding disorder 181 test
  • Platelet-type bleeding disorder 81 test
  • Polycystic kidney disease 21 test
  • Polycystic kidney disease, adult type1 test
  • Pseudo von Willebrand disease1 test
  • Quebec platelet disorder1 test
  • Radial aplasia-thrombocytopenia syndrome1 test
  • Radioulnar synostosis with amegakaryocytic thrombocytopenia 11 test
  • Stormorken syndrome1 test
  • Thrombocythemia 11 test
  • Thrombocytopenia 21 test
  • Thrombocytopenia 41 test
  • Thrombocytopenia 51 test
  • Thrombocytopenia, X-linked, with or without dyserythropoietic anemia1 test
  • Upshaw-Schulman syndrome3 tests
  • von Willebrand disease type 14 tests
  • von Willebrand disease type 23 tests
  • Von Willebrand disease type 2A1 test
  • Von Willebrand disease type 2B1 test
  • von Willebrand disease type 34 tests
  • Warfarin response2 tests
  • Wiskott-Aldrich syndrome2 tests
  • X-linked Alport syndrome1 test
  • X-linked lymphoproliferative disease due to XIAP deficiency1 test

List of services

  • Clinical Testing/Confirmation of Mutations Identified Previously
  • Custom Deletion/Duplication Testing
  • Custom Sequence Analysis
  • Result interpretation

List of certifications/licenses


  • CLIAHelp, Number: 05D1019489, Expiration date: 2021-08-07


  • CA - California Department of Public Health CDPH, Number: CLF11803, Expiration date: 2021-12-28

Participation in external programs

Standardization programs

  • Mutation-specific Databases

Data exchange Programs

  • Mutation-specific Databases

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.